| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.5 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |